Every cloud has a silver lining: Portugal's loss may be the UK's gain
This article was originally published in SRA
Executive Summary
The innovator pharmaceutical industry was disappointed by a recent CJEU ruling relating to supplementary protection certificates in Portugal. However, there could be a positive flip side, writes Mike Snodin.